 Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 11 | 11 | | 1997 | 0 | 26 | 26 | | 1998 | 0 | 19 | 19 | | 1999 | 0 | 17 | 17 | | 2000 | 0 | 20 | 20 | | 2001 | 0 | 17 | 17 | | 2002 | 0 | 21 | 21 | | 2003 | 0 | 18 | 18 | | 2004 | 0 | 21 | 21 | | 2005 | 0 | 33 | 33 | | 2006 | 0 | 42 | 42 | | 2007 | 0 | 37 | 37 | | 2008 | 0 | 47 | 47 | | 2009 | 0 | 38 | 38 | | 2010 | 1 | 46 | 47 | | 2011 | 1 | 59 | 60 | | 2012 | 1 | 49 | 50 | | 2013 | 0 | 75 | 75 | | 2014 | 2 | 99 | 101 | | 2015 | 0 | 80 | 80 | | 2016 | 2 | 84 | 86 | | 2017 | 2 | 101 | 103 | | 2018 | 1 | 86 | 87 | | 2019 | 0 | 95 | 95 | | 2020 | 0 | 77 | 77 | | 2021 | 0 | 46 | 46 | | 2022 | 0 | 8 | 8 | | 2023 | 0 | 8 | 8 | | 2024 | 0 | 59 | 59 | | 2025 | 0 | 53 | 53 | | 2026 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Alderuccio JP, Baggio D, Han S, Ghione P, Nizamuddin I, Khwaja J, Saha A, Dong N, Wang Y, Cherng HJ, Tolu S, Wagner-Johnston N, Ollila TA, Grover N, Koff JL, Desai A, Ramakrishnan Geethakumari P, Moyo TK, Sandoval-Sus J, Epperla N, Wallace DS, Kamdar M, Tavarozzi R, Danilov A, Tun H, Munoz J, Narkhede M, Rhodes JM, Prica A, Kuhnl A, Maraj A, Okosun J, Smith J, Osborne W, Calvert V, El-Sharkawi D, Hilali A, Collins GP, Linton K, Elmusharaf N, Santarsieri A, Karim F, Baidoun F, Monick SE, Trutzer IM, Can J, Ayers A, Calabrese De Feo J, Sharp J, Ghosh N, Treitman R, Kallam A, Okcu I, Abeyakoon C, Hann W, Barrett A, Deshani V, Kahl BS, Chavez JC, Olszewski AJ, Cwynarski K. Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma. Blood. 2026 Apr 16; 147(16):1814-1827.
-
Federico A, Schmitt-Hoffner F, Fonseca A, Geisemeyer N, Bruckner K, Mauermann M, Sill M, Stichel D, Sturm D, Schüller U, Tauziede-Espariat A, Varlet P, Capper D, Abdullaev Z, Schrimpf D, Selt F, Williamson L, Donson AM, Antonelli M, Miele E, Snuderl M, Brandner S, Lastowska M, van der Lugt J, Bunt J, Kramm C, Kolenova A, Raghunathan A, Wilson Y, Weintraub L, Hansford JR, Spiegl-Kreinecker S, Aistleitner B, Baroni L, Zapotocky M, Ramaswamy V, Korshunov A, Jones B, Kjaersgaard M, Kranendonk ME, Haberler C, Packer RJ, Jäger N, von Deimling A, Sahm F, Koster J, Aldape K, Pfister SM, von Hoff K, Gojo J, Kool M. Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies. Neuro Oncol. 2026 Apr 01; 28(4):1005-1019.
-
Anigbogu C, Cotton JL, Su Y, Reece TB, Aftab M, Hoffman JR, Cleveland JC, Rove JY. Ten-Year All-Cause Mortality Following CABG: A Sex-Stratified Analysis of Revascularization. Am J Cardiol. 2026 May 15; 267:44-50.
-
Tsybulskyi D, Hashimoto D, Tanaka K, Murotani K, Taguri M, Yamaki S, Sato S, Oba A, Inoue Y, Otsuka S, Ohgi K, Sugiura T, Shintakuya R, Okada K, Uemura K, Inoue K, Mizuma M, Unno M, Asano T, Nakagawa N, Takami H, Takahashi R, Motoi F, Akahoshi K, Ban D, Gulla A, Ishikawa H, Hirano S, Satoi S. Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. J Hepatobiliary Pancreat Sci. 2026 Mar; 33(3):216-227.
-
Jansson H, Taflin H, Björnsson B, Urdzik J, Hemmingsson O, Rystedt JL, Gilg S, Sandström P, Sparrelid E. Outcomes After Resection for Multiple Intrahepatic Cholangiocarcinoma-A National Population-Based Study. Ann Surg Oncol. 2026 Apr; 33(4):2917-2925.
-
Boysen M, Lai SH, Byers S, Widmar M, Loria A, Russell T, Abelson JS, Fleming FJ, Monson JR, Vogel JD. Rectal Cancer Watch-and-Wait Management of Patients With Tumors Within Versus Beyond the Reach of Digital Rectal Examination. Ann Surg Oncol. 2026 Apr; 33(4):2856-2864.
-
Miyata T, Oba A, Kato T, Maekawa A, Tsuchiya S, Baba H, Tauchi J, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Iwatsuki M, Matsueda K, Inoue Y, Takahashi Y. Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection. Ann Surg Oncol. 2026 Apr; 33(4):3535-3544.
-
Nebbia M, Villard C, Gilg S, Sparrelid E, Gerling M, Engstrand J. Sex-Associated Aspects of Referral, Resectability, and Survival in Patients with Colorectal Liver Metastases (CRLM): A Population-Based Single-Center Study of 1207 MDT-Referred Patients. Ann Surg Oncol. 2026 Mar; 33(3):2527-2538.
-
Akabane M, Baldo A, Kawashima J, Woldesenbet S, Lesurty M, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Beyond the composite: Differential impact of albumin and bilirubin relative to tumor burden in HCC. Eur J Surg Oncol. 2026 Feb; 52(2):111309.
-
O'Brien C, Nursimulu N, Tyagi A, Culp-Hill R, Arruda A, Murphy T, Minden MD, Kent A, Stevens B, Pollyea DA, Hope K, Kumar S, Reisz JA, D'Alessandro A, Jones CL. Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia. Blood. 2025 Nov 20; 146(21):2589-2596.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|